Literature DB >> 20546877

TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer.

Takahiro Yamada1, Takashi Ueda, Yasuhiro Shibata, Yosuke Ikegami, Masaki Saito, Yusuke Ishida, Shinya Ugawa, Kenjiro Kohri, Shoichi Shimada.   

Abstract

OBJECTIVES: To investigate the functional expression of the transient receptor potential vanilloid 2 (TRPV2) channel protein in human urothelial carcinoma (UC) cells and to determine whether calcium influx into UC cells through TRPV2 is involved in apoptotic cell death.
MATERIAL AND METHODS: The expression of TRPV2 mRNA in bladder cancer cell lines (T24, a poorly differentiated UC cell line and RT4, a well-differentiated UC cell line) was analyzed using reverse transcriptase-polymerase chain reaction. The calcium permeability of TRPV2 channels in T24 cells was investigated using a calcium imaging assay that used cannabidiol (CBD), a relatively selective TRPV2 agonist, and ruthenium red (RuR), a nonselective TRPV channel antagonist. The death of T24 or RT4 cells in the presence of CBD was evaluated using a cellular viability assay. Apoptosis of T24 cells caused by CBD was confirmed using an annexin-V assay and small interfering RNA (siRNA) silencing of TRPV2.
RESULTS: TRPV2 mRNA was abundantly expressed in T24 cells. The expression level in UC cells was correlated with high-grade disease. The administration of CBD increased intracellular calcium concentrations in T24 cells. In addition, the viability of T24 cells progressively decreased with increasing concentrations of CBD, whereas RT4 cells were mostly unaffected. Cell death occurred via apoptosis caused by continuous influx of calcium through TRPV2.
CONCLUSIONS: TRPV2 channels in UC cells are calcium-permeable and the regulation of calcium influx through these channels leads directly to the death of UC cells. TRPV2 channels in UC cells may be a potential new therapeutic target, especially in higher-grade UC cells. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546877     DOI: 10.1016/j.urology.2010.03.029

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  27 in total

Review 1.  From urgency to frequency: facts and controversies of TRPs in the lower urinary tract.

Authors:  Roman Skryma; Natalia Prevarskaya; Dimitra Gkika; Yaroslav Shuba
Journal:  Nat Rev Urol       Date:  2011-10-04       Impact factor: 14.432

2.  Expression and distribution of transient receptor potential (TRP) channels in bladder epithelium.

Authors:  Weiqun Yu; Warren G Hill; Gerard Apodaca; Mark L Zeidel
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-13

3.  Potential role of transient receptor potential (TRP) channels in bladder cancer cells.

Authors:  Hideki Mizuno; Yoshiro Suzuki; Masaki Watanabe; Takaaki Sokabe; Tokunori Yamamoto; Ryohei Hattori; Momokazu Gotoh; Makoto Tominaga
Journal:  J Physiol Sci       Date:  2014-05-22       Impact factor: 2.781

4.  Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor.

Authors:  Atsushi Shiozaki; Michihiro Kudou; Daisuke Ichikawa; Hitoshi Fujiwara; Hiroki Shimizu; Takeshi Ishimoto; Tomohiro Arita; Toshiyuki Kosuga; Hirotaka Konishi; Shuhei Komatsu; Kazuma Okamoto; Yoshinori Marunaka; Eigo Otsuji
Journal:  J Gastroenterol       Date:  2017-04-07       Impact factor: 7.527

Review 5.  What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?

Authors:  Alex Perálvarez-Marín; Pau Doñate-Macian; Rachelle Gaudet
Journal:  FEBS J       Date:  2013-05-28       Impact factor: 5.542

6.  Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.

Authors:  Liting Deng; Lindsay Ng; Tatsuya Ozawa; Nephi Stella
Journal:  J Pharmacol Exp Ther       Date:  2016-11-07       Impact factor: 4.030

7.  Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Kun Zhou; Shui-Shen Zhang; Yan Yan; Song Zhao
Journal:  Med Oncol       Date:  2014-05-31       Impact factor: 3.064

Review 8.  Ion channels in cancer: future perspectives and clinical potential.

Authors:  Florian Lang; Christos Stournaras
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

9.  Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium.

Authors:  Yehoshua Maor; Jinlong Yu; Paula M Kuzontkoski; Bruce J Dezube; Xuefeng Zhang; Jerome E Groopman
Journal:  Genes Cancer       Date:  2012-07

10.  Bystander effects induced by the interaction between urothelial cancer cells and irradiated adipose tissue-derived stromal cells in urothelial carcinoma.

Authors:  Maki Kawasaki; Kei Nagase; Shigehisa Aoki; Kazuma Udo; Shohei Tobu; Mihoko Rikitake-Yamamoto; Masaya Kubota; Takayuki Narita; Mitsuru Noguchi
Journal:  Hum Cell       Date:  2022-01-19       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.